PELICAN HEALTH LIMITED

Pelican Health Limited is a cutting‑edge life‑science company dedicated to revolutionising the study of the small intestine and its microbiome. By delivering the first non‑invasive, spatially precise sampling solution, Pelican enables researchers and clinicians to obtain contamination‑free specimens from exact locations within the small intestine – a region that has traditionally been difficult to access without invasive procedures.

The company’s flagship Pelican Sampling system guides the sample through a seamless workflow of ingestion, transit, targeted sampling, recovery and analysis. This technology provides reliable, location‑specific data that overcomes the limitations of fecal proxies and conventional methods, opening new avenues for the prevention, diagnosis and treatment of gastrointestinal pathologies such as inflammatory bowel disease, celiac disease, metabolic syndrome and even broader conditions linked to the gut microbiome.

Pelican Health serves healthcare professionals, academic researchers and pharmaceutical partners seeking deeper insight into the gut‑organ axis, with the ultimate aim of improving patient outcomes through more accurate, personalised therapeutic strategies.